Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CellsFromSpace: a fast, accurate, and reference-free tool to deconvolve and annotate spatially distributed omics data.
Thuilliez C, Moquin-Beaudry G, Khneisser P, Marques Da Costa ME, Karkar S, Boudhouche H, Drubay D, Audinot B, Geoerger B, Scoazec JY, Gaspar N, Marchais A. Thuilliez C, et al. Among authors: scoazec jy. Bioinform Adv. 2024 May 30;4(1):vbae081. doi: 10.1093/bioadv/vbae081. eCollection 2024. Bioinform Adv. 2024. PMID: 38915885 Free PMC article.
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models.
da Costa MEM, Droit R, Khneisser P, Gomez-Brouchet A, Adam-de-Beaumais T, Nolla M, Signolles N, Torrejon J, Lombard B, Loew D, Ayrault O, Scoazec JY, Geoerger B, Vassal G, Marchais A, Gaspar N. da Costa MEM, et al. Among authors: scoazec jy. Front Oncol. 2023 Jun 12;13:1166063. doi: 10.3389/fonc.2023.1166063. eCollection 2023. Front Oncol. 2023. PMID: 37377921 Free PMC article.
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers.
Lim WC, Marques Da Costa ME, Godefroy K, Jacquet E, Gragert L, Rondof W, Marchais A, Nhiri N, Dalfovo D, Viard M, Labaied N, Khan AM, Dessen P, Romanel A, Pasqualini C, Schleiermacher G, Carrington M, Zitvogel L, Scoazec JY, Geoerger B, Salmon J. Lim WC, et al. Among authors: scoazec jy. Front Immunol. 2024 Jan 22;14:1265469. doi: 10.3389/fimmu.2023.1265469. eCollection 2023. Front Immunol. 2024. PMID: 38318504 Free PMC article.
Image-guided core biopsy for pelvic lesions of unknown origin.
Batlle C, Faron M, Deschamps F, Najafi A, Kobe A, Bonnet B, Hakimé A, Territehau C, Gouy S, Mir O, Scoazec JY, de Baere T, Honoré C, Tselikas L. Batlle C, et al. Among authors: scoazec jy. Br J Surg. 2024 Jan 3;111(1):znad351. doi: 10.1093/bjs/znad351. Br J Surg. 2024. PMID: 37943798 No abstract available.
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
Bigot L, Sabio J, Poiraudeau L, Annereau M, Menssouri N, Helissey C, Déas O, Aglave M, Ibrahim T, Pobel C, Nobre C, Nicotra C, Ngo-Camus M, Lacroix L, Rouleau E, Tselikas L, Judde JG, Chauchereau A, Bernard-Tessier A, Patrikidou A, Naoun N, Flippot R, Colomba E, Fuerea A, Albiges L, Lavaud P, Massard C, Friboulet L, Fizazi K, Besse B, Scoazec JY, Loriot Y. Bigot L, et al. Among authors: scoazec jy. Eur Urol Oncol. 2024 Jun;7(3):527-536. doi: 10.1016/j.euo.2023.10.011. Epub 2023 Oct 27. Eur Urol Oncol. 2024. PMID: 38433714
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development.
Vasseur D, Bigot L, Beshiri K, Flórez-Arango J, Facchinetti F, Hollebecque A, Tselikas L, Aldea M, Blanc-Durand F, Gazzah A, Planchard D, Lacroix L, Pata-Merci N, Nobre C, Da Silva A, Nicotra C, Ngo-Camus M, Braye F, Nikolaev SI, Michiels S, Jules-Clement G, Olaussen KA, André F, Scoazec JY, Barlesi F, Ponce S, Soria JC, Besse B, Loriot Y, Friboulet L. Vasseur D, et al. Among authors: scoazec jy. Mol Cancer. 2024 Oct 4;23(1):221. doi: 10.1186/s12943-024-02134-4. Mol Cancer. 2024. PMID: 39363320 Free PMC article.
716 results